Skip to main content

USANS - February 2014

By
Just catching up on some recently published USAN statements.

USAN Research Code InChIKey (Parent) Drug Class Therapeutic class Target
asvasiran-sodium

ALN-RSV01

 n/a RNAi therapeutic n/a
beclabuvir

BMS-791325

 ZTTKEBYSXUCBSE-VSBZUFFNSA-N synthetic small molecule therapeutic HCV NS5B polymerase
benzhydrocodone, benzhydrocodone-hydrochloride
KP-201
 VPMRSLWWUXNYRY-PJCFOSJUSA-N natural product derived small molecule therapeutic Opioid receptors
bradanicline, bradanicline-hydrochloride

TC-5619

 OXKRFEWMSWPKKV-GHTZIAJQSA-N synthetic small molecule therapeutic alpha-7 nicotinic acetylcholine receptor
briciclib, briciclib-sodium

ON-014185

 LXENKEWVEVKKGV-BQYQJAHWSA-N synthetic small molecule therapeutic n/a
ceritinib

NVP-LDK378-NX

 VERWOWGGCGHDQE-UHFFFAOYSA-N synthetic small molecule therapeutic ALK
dasabuvir

ABT-333

 NBRBXGKOEOGLOI-UHFFFAOYSA-N synthetic small molecule therapeutic HCV NS5B polymerase
defactinib, defactinib-hydrochloride

VS-6063

 FWLMVFUGMHIOAA-UHFFFAOYSA-N synthetic small molecule therapeutic FAK
dianhydrogalactitol

VAL-083, NSC-1323313

 AAFJXZWCNVJTMK-UHFFFAOYSA-N synthetic small molecule therapeutic DNA
dinutuximab
n/a
 n/a monoclonal antibody therapeutic GD2
diridavumab

CR-6261

 n/a monoclonal antibody therapeutic haemagglutinin
encenicline, encenicline-hydrochloride

EVP-6124

 SSRDSYXGYPJKRR-ZDUSSCGKSA-N synthetic small molecule therapeutic alpha-7 nicotinic acetylcholine receptor
esuberaprost, esuberaprost-sodium


APS-314d, BPS-314d

 CTPOHARTNNSRSR-NOQAJONNSA-N synthetic small molecule therapeutic IP1 receptor
filociclovir


MBX-400

 KMUNHOKTIVSFRA-KXFIGUGUSA-N synthetic small molecule therapeutic CMV DNA polymerase
fosdagrocorat

PF-04171327

 n/a synthetic small molecule therapeutic GR
gedatolisib

PF-05212384, PKI-587

 DWZAEMINVBZMHQ-UHFFFAOYSA-N synthetic small molecule therapeutic PI3K & mTOR
glasdegib

PF-04449913

 SFNSLLSYNZWZQG-VQIMIIECSA-N synthetic small molecule therapeutic smoothened
indoximod
D-1MT
 n/a natural product derived small molecule therapeutic IDO
latiglutenase

ALV-003

 n/a enzyme therapeutic n/a
lulizumab-pegol BMS-931699

 n/a monoclonal antibody therapeutic CD28
ombitasvir

ABT-267

 PIDFDZJZLOTZTM-KHVQSSSXSA-N synthetic small molecule therapeutic HCV NS5a
omega-3-carboxylic-acids
n/a
 n/a natural product derived small molecule therapeutic n/a
peficitinib

ASP-015K

 DREIJXJRTLTGJC-UHFFFAOYSA-N synthetic small molecule therapeutic JAK
pegargiminase
n/a
 n/a enzyme therapeutic n/a
pembrolizumab
n/a
 n/a monoclonal antibody therapeutic Programmed cell death 1 (PDCD1)
polmacoxib

CG-100649

 IJWPAFMIFNSIGD-UHFFFAOYSA-N synthetic small molecule therapeutic COX-2
sarolaner

PF-6450567

 FLEFKKUZMDEUIP-QFIPXVFZSA-N synthetic small molecule therapeutic n/a
transcrocetinate-sodium
n/a
 n/a natural product derived small molecule radiation sensitizer n/a
uprosertib

GSK-2141795C

 AXTAPYRUEKNRBA-JTQLQIEISA-N synthetic small molecule therapeutic AKT1
venetoclax

ABT-199

 LQBVNQSMGBZMKD-UHFFFAOYSA-N synthetic small molecule therapeutic BCL-2

Comments

Post a Comment

Popular posts from this blog

Improvements in SureChEMBL's chemistry search and adoption of RDKit

By Eloy
    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by
Post a Comment
Read more

Improved querying for SureChEMBL

By
    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never
Post a Comment
Read more

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

By
In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen
Post a Comment
Read more

ChEMBL 34 is out!

By
We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.
Post a Comment
Read more

In search of the perfect assay description

By
Credit: Science biotech, CC BY-SA 4.0 Assays des cribe the experimental set-up when testing the activity of drug-like compounds against biological targets; they provide useful context for researchers interested in drug-target relationships. Ver sion 33 of ChEMBL contains 1.6 million diverse assays spanning ADMET, physicochemical, binding, functional and toxicity experiments. A set of well-defined and structured assay descriptions would be valuable for the drug discovery community, particularly for text mining and NLP projects. These would also support ChEMBL's ongoing efforts towards an  in vitro  assay classification. This Blog post will consider the features of the 'perfect' assay description and provide a guide for depositors on the submission of high quality data. ChEMBL's assays are typically structured with the overall aim, target, and method .  The ideal assay description is succinct but contains all the necessary information for easy interpretation by database u
Post a Comment
Read more